Lucio Claudio Rovati,Massimo Maria D'Amato,Ulrich Mengs,Ralf-Torsten Pohl,Peter Ferenci,Massimo Maria DAmato
申请号：
US13871045
公开号：
US09248115B2
申请日:
2013.04.26
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The invention relates to the use of a silibinin component for the production of a medicament that is adapted for parenteral administration for the treatment of viral hepatitis, preferably of hepatitis B or C, in particular for the reduction of the virus load. The medicament preferably contains no silidianin and/or no silichristin and/or no isosilibinin.
